| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 36.9 | 25.2 | 22.4 |
| Total income | 36.9 | 25.2 | 22.4 |
| Profit before exceptional items & tax | 1.1 | 1.2 | 0.2 |
| Profit before tax | 1.1 | 1.2 | 0.2 |
| Net profit | 1.2 | 0.9 | 0.1 |
| Operating margin | 3.0% | 4.8% | 0.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +1100.00% |
|---|---|
| Net profit, quarter on quarter | +33.30% |
| Revenue, year on year | +64.70% |
BSE results filing, NSE: TRIMURTHI. Figures extracted from the filing.
Novelix Pharmaceuticals Ltd: key numbers
- Share price
- ₹71.95
- Market cap
- ₹126.7 Cr
- Revenue (annual)
- ₹132.3 Cr
- Net profit (annual)
- ₹2.56 Cr
- P/E (TTM)
- 34.9×Sector 66.8×
- Promoter holding
- 54.29%+4.86% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Novelix Pharmaceuticals Ltd
All →Novelix Pharmaceuticals Other Announcement
Novelix Pharmaceuticals informs shareholders that the Annual Report for FY 2025-26 and the 32nd AGM notice are available on the Company's website.
Novelix Pharmaceuticals Annual Report
Novelix Pharmaceuticals filed its Annual Report and AGM Notice for the financial year 2025-26. The 32nd Annual General Meeting is scheduled for September 30, 2026.
Novelix Pharmaceuticals Annual General Meeting
Novelix Pharmaceuticals Limited will hold its 32nd Annual General Meeting on September 30, 2026. The company has fixed September 23, 2026, as the cut-off date for e-voting.
Novelix Pharmaceuticals Management Change
Novelix Pharmaceuticals Limited appointed Mr. Gnana Prakash Gattu as Whole-time Director for a five-year term. The appointment, effective August 29, 2026, awaits shareholder approval.
- Execution
- 5 years
Novelix Pharmaceuticals Board Meeting Outcome
Novelix Pharmaceuticals Ltd approved the AGM notice and appointed Mr. Gnana Prakash Gattu as a Whole-time Director in its board meeting outcome.
Novelix Pharmaceuticals Board Meeting Date
Novelix Pharmaceuticals Limited will hold a board meeting on August 29, 2026, to discuss the AGM notice, annual report, and a director appointment.